VI
CVS icon

Vestcor Inc’s CVS Health CVS Stock Holding History

Vestcor Inc’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Sell
33,855
-12,291
-27% -$1.1M 0.09% 235
2026
Q1 		$3.31M Buy
46,146
+4,197
+10% +$323K 0.09% 230
2025
Q4 		$3.33M Buy
41,949
+5,108
+14% +$403K 0.09% 224
2025
Q3 		$2.78M Sell
36,841
-2,167
-6% -$149K 0.08% 258
2025
Q2 		$2.69M Buy
39,008
+15,171
+64% +$995K 0.08% 271
2025
Q1 		$1.61M Sell
23,837
-279
-1% -$16.7K 0.05% 325
2024
Q4 		$1.08M Sell
24,116
-26
-0.1% -$1.46K 0.04% 425
2024
Q3 		$1.52M Sell
24,142
-19,772
-45% -$1.15M 0.05% 354
2024
Q2 		$2.59M Hold
43,914
– – 0.09% 233
2024
Q1 		$3.5M Sell
43,914
-3,738
-8% -$286K 0.12% 190
2023
Q4 		$3.76M Sell
47,652
-288
-0.6% -$20.5K 0.13% 172
2023
Q3 		$3.35M Sell
47,940
-8,667
-15% -$614K 0.12% 179
2023
Q2 		$3.91M Sell
56,607
-2,006
-3% -$143K 0.14% 162
2023
Q1 		$4.36M Sell
58,613
-116
-0.2% -$9.73K 0.16% 149
2022
Q4 		$5.47M Buy
58,729
+247
+0.4% +$23.8K 0.2% 115
2022
Q3 		$5.58M Buy
58,482
+287
+0.5% +$28.4K 0.21% 109
2022
Q2 		$5.39M Buy
58,195
+9,736
+20% +$950K 0.2% 109
2022
Q1 		$4.91M Buy
48,459
+10,897
+29% +$1.14M 0.17% 138
2021
Q4 		$3.88M Sell
37,562
-5,408
-13% -$500K 0.14% 171
2021
Q3 		$3.65M Sell
42,970
-3,068
-7% -$257K 0.13% 190
2021
Q2 		$3.84M Sell
46,038
-2,795
-6% -$229K 0.13% 193
2021
Q1 		$3.67M Buy
48,833
+15,331
+46% +$1.12M 0.14% 195
2020
Q4 		$2.29M Buy
33,502
+1,596
+5% +$104K 0.1% 260
2020
Q3 		$1.86M Buy
31,906
+3,929
+14% +$244K 0.09% 258
2020
Q2 		$1.82M Buy
27,977
+123
+0.4% +$7.75K 0.09% 233
2020
Q1 		$1.65M Buy
27,854
+5,294
+23% +$353K 0.09% 238
2019
Q4 		$1.68M Buy
+22,560
New +$1.58M 0.08% 276

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vestcor Inc's CVS Position: Q2 2026 in Review

Vestcor Inc reduced its CVS Health (CVS) stake by 27% in Q2 2026, selling an estimated $1.1M and leaving 33,855 shares worth $3.5M. The position accounts for 0.09% of the portfolio, ranked #235.

Vestcor Inc first reported a position in CVS in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.58M in Q3 2022. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Vestcor Inc held 33,855 shares of CVS Health worth $3.5M as of Q2 2026.
  • Vestcor Inc sold 12,291 CVS Health shares in Q2 2026, an estimated $1.1M.
  • CVS Health made up 0.09% of Vestcor Inc's portfolio in Q2 2026, its #235 holding.
  • Vestcor Inc first reported a position in CVS Health in Q4 2019 and has held it in 27 quarters since.
  • Vestcor Inc's CVS Health position peaked at $5.58M in Q3 2022.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.